Ignite Creation Date:
2024-05-05 @ 7:10 PM
Last Modification Date:
2024-10-26 @ 9:44 AM
Study NCT ID:
NCT00616564
Status:
COMPLETED
Last Update Posted:
2012-05-03
First Post:
2008-02-04
Brief Title:
Phase II Trial of IL-2 With Priming and GM-CSF in Patients With Advanced Melanoma
Sponsor:
Mt Sinai Medical Center Miami
Organization:
Mt Sinai Medical Center Miami
Organization Data
Organization:
Mt Sinai Medical Center Miami
Class:
OTHER
Study ID:
MEL0105
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Mt Sinai Medical Center Miami
Lead Sponsor Class:
OTHER
Responsible Party:
Jose Lutzky
Responsible Party Title:
Principal Investigator Jose Lutzky MD
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Mt Sinai Medical Center Miami
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Chiron Corporation | INDUSTRY |
| Bayer | INDUSTRY |